IGF1 and retinopathy of prematurity: Moreover, their finding that recombinant human IGF1 (rh-IGF1) treatment reduced neovascularization and improved retinal revascularization underscores the therapeutic potential of IGF1, aligning with our conclusion that IGF1 levels play a crucial role in ROP development.